Systematic identification and targeting of master regulator checkpoints (MRC) governing tumor microenvironment-mediated immune evasion
Abrogating the immunoevasive role of the tumor immune microenvironment (TIME) represents a critical yet still elusive challenge in cancer treatment. Progress in this area has been hampered by both technological limitations and incomplete understanding…